期刊文献+

hTERT启动子调控的HSV-tk基因逆转录病毒载体的构建及SKOV3转染细胞的生物学特性观察 被引量:3

Changes of biological character of SKOV3 cells transfected with HSV-tk gene under the control of hTERT promoter
下载PDF
导出
摘要 目的 :观察转染有人端粒酶逆转录酶基因 (humantelomerasereversetranscriptase,hTERT)启动子调控的单纯疱疹病毒Ⅰ型胸苷激酶 (herpessimplexvirusthymidinekinase ,HSV tk)基因的人卵巢癌细胞的部分生物学特性。方法 :构建hTERT启动子调控的HSV tk基因重组逆转录病毒载体 ,筛选携带该载体的包装细胞 ,测定包装细胞产生的逆转录病毒滴度 ,并用病毒颗粒感染人卵巢癌SKOV3细胞 (SKOV3/tk细胞 )并经RT PCR方法鉴定。然后倒置显微镜下观察SKOV3/tk细胞形态 ,MTT法研究细胞生长特性 ,并观察转染细胞裸鼠体内的成瘤能力。结果 :包装细胞产生的病毒滴度可达 2× 1 0 3 cfu·ml-1 。SKOV3/tk细胞扩增出 770bp的tk基因片段 ,形态与SKOV3细胞无明显差异 ;倍增时间 72h ,无明显变化 ;裸鼠体内的成瘤能力较SKOV3细胞下降。结论 :hTERT调控的HSV tk基因逆转录病毒载体构建成功 ; Aim: To identify the difference between transfected human ovarian cancer cells with HSV tk gene under the control of hTERT promoter and non transfected cells. Methods: The first step was to select packaging cells with high retrovirus titer by G418 . The human ovarian cancer cell line SKOV3 was transfected with the recombinant retrovirus containing HSV tk gene. Positive clones were identified by RT PCR and then the growth rate, phenotype, and heterotransplantative tumourigenecity were observed, respectively. Results: The positive packaging cells were obtained with the titer of 2×10 3 cfu·ml -1 . 770 bp fragment was amplified by RT PCR from the selected cells. The growth rate and phenotype of transfected cells were almost the same as the wild type cells. The heterotransplantative tumourigenecity and the growth rate of the tumour in nude mice decreased compared with non transfected cells. Conclusion: The heterotransplantative tumourigenecity of transfected human ovarian cancer cells with HSV tk gene under the control of hTERT promoter decreased.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第4期566-569,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省重大科技攻关基金资助项目 0 12 2 0 3 2 5 0 0
关键词 HTERT启动子 HSV-TK基因 卵巢癌细胞 逆转录病毒载体 hTERT promoter HSV tk gene ovarian cancer vector
  • 相关文献

参考文献7

二级参考文献23

  • 1姜泊 张亚历 等.分子生物学常用实验方法[M].北京:人民军医出版社,1998.88-94.
  • 2萨姆布鲁克 DM拉塞尔著 黄培堂译.分子克隆实验指南:第3版[M].北京:科学出版社,2003.26.
  • 3Nagy H,Panis Y,Fabre M ,et al. Are hepatomas a good target for suicide gene therapy? An experimental study in rats using retroviral-mediated transfer of thymidine kinase gene. Surgery, 1998, 123(1) :19.
  • 4Miyauchi M, Shimada H, Kadomatsu K, et al. Frequent expression of midkine gene in Esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res, 1999, 90(4) : 469.
  • 5Ishii H, Dumon KR, Vecchione A, et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res, 2001,61 (4) :1 578.
  • 6Meyerson M, Counter CM, Eaton EN, et al. hEST2,the putative human telomerase catalytic suhunit gene,is up-regula-ted in tumor cells and during immortalization. Cell, 1997,90(4) :785.
  • 7Cong YS, Wen J, Bacchetti S. The human telomerase catalytic suhunit hTERT:organization of the gene and characterization of the promoter. Hum Mol Genet,1999,8(1) :137.
  • 8Horikawa I, Cable PL, Afshari C, et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res, 1999,59(4) :826.
  • 9Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science, 1994,263(5 148) :802.
  • 10Kim NW, Piatyszek MA, Prowse KR, et al. Specific associatinn of human telomerase activity with immortal cells and cancer. Science,1994,266(5 193) :2011.

共引文献8

同被引文献21

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部